What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2023-03-31 compared with 2022-04-01 · 40 added, 20 removed, 34 unchanged (64% of the section changed)

16 unchanged sentences

available funds for the development of our business.

Securities Authorized for Issuance under Equity

Compensation Agreements

Securities Authorized for Issuance

under Equity Compensation Agreements

The following table gives information concerning

3 unchanged sentences

Plan category

available for

of securities to

be issued upon exercise

of outstanding options,

warrants and rights

Weighted average

exercise price of

outstanding options,

warrants, and rights ($)

of securities

remaining available for

future issuance under

equity compensation

plans (excluding

securities reflected in

column a) (#)

As of December 31, 2022

3 unchanged sentences

changes is set forth below:

On November 10, 2017, the board of directors adopted the 2017 Equity Incentive Plan (the “Plan”) pursuant to which we can issue up to 150,000,000 shares of common stock pursuant to non-qualified stock options, restricted stock grants and other equity-based incentives.

On February 19, 2021, the board of directors amended the Plan increasing the shares we can issue under the plan to 500,000,000 shares of common stock pursuant to non-qualified stock options, restricted stock grants and other equity-based incentives, and the amendment to the Plan became effective upon the closing of the agreements with QFL, which was February 22, 2021.

(1) On November 10, 2017, the board of directors adopted the

2017 Equity Incentive Plan (the “Plan”) pursuant to which we can issue up to 1,500,000 shares of common stock pursuant to

non-qualified stock options, restricted stock grants and other equity-based incentives.

On February 19, 2021, the board of directors

amended the Plan increasing the shares we can issue under the plan to 5,000,000 shares of common stock pursuant to non-qualified stock

options, restricted stock grants and other equity-based incentives, and the amendment to the Plan became effective upon the closing of

the agreements with QFL, which was February 22, 2021.

At December 31, 2022, 1,760,000 shares are available under the plan.

1 unchanged sentence

of common stock issuable pursuant to the plan, the board in 2021;

● granted restricted stock grants for 10,000,000 shares, which vested

immediately, to each of three consultants pursuant to agreements with the consultants;

restricted stock grants for a total of 69,000,000 shares to our directors, Jon C.

● granted restricted stock grants for 100,000 shares, which

vested immediately, to each of three consultants pursuant to agreements with the consultants;

● granted restricted stock grants for a total of 690,000 shares

to our directors, Jon C.

Scahill (490,000 shares), Timothy J.

Scahill (10,000,000

shares) and Dr.

Carroll (10,000,000 shares) as compensation for services rendered;

a restricted stock grant to Ryan T.

Logue for 5,000,000 shares upon his acceptance of his appointment as a director;

ten-year non-qualified stock options to purchase 30,000,000 shares to each of three consultants pursuant to agreements with the consultants,

the options to vest as provided in their agreements;

a ten-year non-qualified stock option to purchase 60,000,000 shares to Jon C.

Scahill, which vest in installments as described under

Scahill (100,000 shares) and Dr.

Carroll (100,000 shares) as

compensation for services rendered;

● granted a restricted stock grant to Ryan T.

Logue for 50,000

shares upon his acceptance of his appointment as a director;

● granted ten-year non-qualified stock options to purchase

300,000 shares to each of three consultants pursuant to agreements with the consultants, the options to vest as provided in their agreements;

● granted a ten-year non-qualified stock option to purchase

600,000 shares to Jon C.

Scahill, which vest in installments as described under Item 11.

Executive Compensation.

1 unchanged sentence

We did not sell any unregistered securities during

since the beginning of the year ended December 31, 2021 other than issuances that were reported in our SEC filings.

We are a smaller reporting company as defined

by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

the year ended December 31, 2022 other than issuances that were reported in our SEC filings.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity